Skip to content
healthcare.dev

VIVIMUSTA

NDC 24338-270, BENDAMUSTINE HYDROCHLORIDE, injection, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-270
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212209
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE25 mg/mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
24338-270-01243380270011 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01) / 4 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4df6548f-c4ad-4eb2-a54f-19766a3d90ca
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=24338-270

Use it

Look up 24338-270 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.